Association Between Metabolic-Associated Fatty Liver Disease and Obstructive Sleep Apnea: A Cross-Sectional Study

References

• Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687–698. doi:10.1016/S2213-2600(19)30198-5
   PubMed Web of Science ®Google Scholar
• Querejeta Roca G, Redline S, Punjabi N, et al. Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study. Am J Respir Crit Care Med. 2013;188(12):1460–1465. doi:10.1164/rccm.201309-1572OC
   PubMed Web of Science ®Google Scholar
• Dredla BK, Castillo PR. Cardiovascular consequences of obstructive sleep apnea. Curr Cardiol Rep. 2019;21(11):137. doi:10.1007/s11886-019-1228-3
   Web of Science ®Google Scholar
• Povitz M, Bolo CE, Heitman SJ, Tsai WH, Wang J, James MT. Effect of treatment of obstructive sleep apnea on depressive symptoms: systematic review and meta-analysis. PLoS Med. 2014;11(11):e1001762.
   PubMed Web of Science ®Google Scholar
• Li M, Li X, Lu Y. Obstructive sleep apnea syndrome and metabolic diseases. Endocrinology. 2018;159(7):2670–2675. doi:10.1210/en.2018-00248
   PubMed Web of Science ®Google Scholar
• Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62(7):569–576. doi:10.1016/j.jacc.2013.05.045
   PubMed Web of Science ®Google Scholar
• Mesarwi OA, Loomba R, Malhotra A. Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease. Am J Respir Crit Care Med. 2019;199(7):830–841. doi:10.1164/rccm.201806-1109TR
   PubMed Web of Science ®Google Scholar
• Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014 e1991. doi:10.1053/j.gastro.2019.11.312
   PubMed Web of Science ®Google Scholar
• Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597–619. doi:10.5664/jcsm.2172
   PubMed Web of Science ®Google Scholar
• Qi JC, Huang JC, Lin QC, et al. Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults. Sleep Breath. 2016;20(2):529–535. doi:10.1007/s11325-015-1232-9
   PubMed Web of Science ®Google Scholar
• Savransky V, Bevans S, Nanayakkara A, et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol. 2007;293(4):G871–877. doi:10.1152/ajpgi.00145.2007
   Web of Science ®Google Scholar
• Agrawal S, Duseja A, Aggarwal A, et al. Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center. Hepatol Int. 2015;9(2):283–291. doi:10.1007/s12072-015-9615-3
   Web of Science ®Google Scholar
• Chen LD, Chen MX, Chen GP, et al. Association between obstructive sleep apnea and non-alcoholic fatty liver disease in pediatric patients: a meta-analysis. Pediatr Obes. 2021;16(3):e12718. doi:10.1111/ijpo.12718
   Web of Science ®Google Scholar
• Kim D, Ahmed A, Kushida C. Continuous positive airway pressure therapy on nonalcoholic fatty liver disease in patients with obstructive sleep apnea. J Clin Sleep Med. 2018;14(8):1315–1322. doi:10.5664/jcsm.7262
   PubMed Web of Science ®Google Scholar
• Aron-Wisnewsky J, Clement K, Pepin JL. Nonalcoholic fatty liver disease and obstructive sleep apnea. Metabolism. 2016;65(8):1124–1135. doi:10.1016/j.metabol.2016.05.004
   PubMed Web of Science ®Google Scholar
• Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev. 2005;9(3):211–224. doi:10.1016/j.smrv.2005.01.006
   PubMed Web of Science ®Google Scholar
• Tasali E, Ip MS. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc. 2008;5(2):207–217. doi:10.1513/pats.200708-139MG
   PubMedGoogle Scholar
• Tomar A, Bhardwaj A, Choudhary A, Bhattacharyya D. Association of obstructive sleep apnea with nocturnal hypoxemia in metabolic-associated fatty liver disease patients: a cross-sectional analysis of record-based data. J Family Med Prim Care. 2021;10(8):3105–3110. doi:10.4103/jfmpc.jfmpc_412_21
   Google Scholar
• Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of Insulin Resistance in MAFLD. Int J Mol Sci. 2021;22(8):4156. doi:10.3390/ijms22084156
   PubMed Web of Science ®Google Scholar
• Arnaud C, Dematteis M, Pepin JL, Baguet JP, Levy P. Obstructive sleep apnea, immuno-inflammation, and atherosclerosis. Semin Immunopathol. 2009;31(1):113–125. doi:10.1007/s00281-009-0148-5
   PubMed Web of Science ®Google Scholar
• Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50:101238.
   PubMed Web of Science ®Google Scholar
• Cheng YM, Kao JH, Wang CC. The metabolic profiles and body composition of lean metabolic associated fatty liver disease. Hepatol Int. 2021;15(2):405–412. doi:10.1007/s12072-021-10147-0
   Web of Science ®Google Scholar
• Chen YL, Li H, Li S, et al. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. BMC Gastroenterol. 2021;21(1):212.
   Web of Science ®Google Scholar
• Tang H, Zhou Q, Zheng F, Wu T, Tang YD, Jiang J. The Causal Effects of Lipid Profiles on Sleep Apnea. Front Nutr. 2022;9:910690. doi:10.3389/fnut.2022.910690
   PubMed Web of Science ®Google Scholar
• Um YJ, Chang Y, Jung HS, et al. Sleep duration, sleep quality, and the development of nonalcoholic fatty liver disease: a cohort study. Clin Transl Gastroenterol. 2021;12(10):e00417.
   Web of Science ®Google Scholar